Analytical Data
-
Gene name
Tsku
- Application
-
Alternative Names
(Leucine-rich repeat-containing protein 54)
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8CBR6
-
Expression Region
18-354aa
-
Molecular Weight
44.0 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of Tsku recombinant protein is rooted in the quest to understand its biological functions and potential applications in biotechnology and medicine. Tsku, a member of the TGF-beta superfamily, has been implicated in various cellular processes, including cell proliferation, differentiation, and apoptosis. Initial research indicated its involvement in embryogenesis and tissue development, making it a subject of interest for developmental biology. As recombinant DNA technology advanced, scientists began to explore the production of Tsku protein in host systems such as bacteria, yeast, or mammalian cells, facilitating the study of its structure and function. Characterizing the Tsku protein through recombinant methods enables researchers to investigate its role in disease states, such as cancer and fibrotic disorders, as well as its potential as a therapeutic agent. Furthermore, the ability to produce Tsku in large quantities allows for the development of diagnostic tools and treatments that target its signaling pathways, underscoring its relevance in both fundamental research and clinical applications.
